Browse > Article
http://dx.doi.org/10.4014/jmb.1311.11057

Effect of Lipopolysaccharide (LPS) on Mouse Model of Steroid-Induced Avascular Necrosis in the Femoral Head (ANFH)  

Ryoo, Soyoon (Laboratory of Cytokine Immunology, Department Biomedical Sciences and Technology, Konkuk University)
Lee, Sukha (Department of Orthopaedic Surgery, School of Medicine, Konkuk University)
Jo, Seunghyun (Laboratory of Cytokine Immunology, Department Biomedical Sciences and Technology, Konkuk University)
Lee, Siyoung (Laboratory of Cytokine Immunology, Department Biomedical Sciences and Technology, Konkuk University)
Kwak, Areum (Laboratory of Cytokine Immunology, Department Biomedical Sciences and Technology, Konkuk University)
Kim, Eunsom (Laboratory of Cytokine Immunology, Department Biomedical Sciences and Technology, Konkuk University)
Lee, Jongho (Laboratory of Cytokine Immunology, Department Biomedical Sciences and Technology, Konkuk University)
Hong, Jaewoo (Laboratory of Cytokine Immunology, Department Biomedical Sciences and Technology, Konkuk University)
Jhun, Hyunjhung (Laboratory of Cytokine Immunology, Department Biomedical Sciences and Technology, Konkuk University)
Lee, Youngmin (Department of Medicine, Pusan Paik Hospital, Collage of Medicine, Inje University)
Sobti, Anshul Shyam (Department of Orthopaedic Surgery, School of Medicine, Konkuk University)
Kim, Soohyun (Laboratory of Cytokine Immunology, Department Biomedical Sciences and Technology, Konkuk University)
Oh, Kwang-Jun (Department of Orthopaedic Surgery, School of Medicine, Konkuk University)
Publication Information
Journal of Microbiology and Biotechnology / v.24, no.3, 2014 , pp. 394-400 More about this Journal
Abstract
Avascular necrosis of the femoral head (ANFH) is commonly observed in patients treated with excessive glucocorticoid (GC). Single administration of lipopolysaccharide (LPS) has shown to induce immune stimulatory factors. However, the effect of repeated administration of LPS on GC-induced ANFH has not been studied. Thus, the purpose of this study was (i) to examine the cytokine profile induced by repeated LPS administrations and (ii) to test the effect of repeated LPS treatments on GC-induced ANFH. A mouse necrosis model of ANFH was designed by chronic GC administration with co-treatment of LPS. Mice body weights in the LPS/prednisolone (PDN) co-treated group were lower than that of the untreated control group, but spleen weights were greater than the control group. The levels of IL-6, $TNF{\alpha}$, and IL-33 in the liver and spleen of the LPS/PDN group were lower than the untreated control group, whereas $TNF{\alpha}$ level in the femoral head of the LPS/PDN group increased. Collectively, the effect of repeated LPS on the pathogenesis of GC-induced ANFH was associated with the $TNF{\alpha}$ level in the femoral head, but the pathogenesis did not correspond to cytokine levels in immune tissues.
Keywords
LPS; mouse model of ANFH; inflammatory cytokine; interleukin-33; cytokine ELISA;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Weinstein RS, Nicholas RW, Manolagas SC. 2000. Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. J. Clin. Endocrinol. Metab. 85: 2907-2912.
2 West MA, Heagy W. 2002. Endotoxin tolerance: a review. Crit. Care Med. 30: S64-S73.   DOI   ScienceOn
3 Ong SL, Whitworth JA. 2011. How do glucocorticoids cause hypertension: role of nitric oxide deficiency, oxidative stress, and eicosanoids. Endocrinol. Metab. Clin. North Am. 40: 393-407, ix.   DOI   ScienceOn
4 Schacke H, Schottelius A, Docke WD, Strehlke P, Jaroch S, Schmees N, et al. 2004. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects. Proc. Natl. Acad. Sci. USA 101: 227-232.   DOI   ScienceOn
5 Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, et al. 2005. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces Thelper type 2-associated cytokines. Immunity 23: 479-490.   DOI   ScienceOn
6 Schulze J, Bickert T, Beil FT, Zaiss MM, Albers J, Wintges K, et al. 2010. Interleukin-33 is expressed in differentiated osteoblasts and blocks osteoclast formation from bone marrow precursor cells. J. Bone Miner. Res. 26: 704-717.
7 Stein NC, Kreutzmann C, Zimmermann SP, Niebergall U, Hellmeyer L, Goettsch C, et al. 2008. Interleukin-4 and interleukin-13 stimulate the osteoclast inhibitor osteoprotegerin by human endothelial cells through the STAT6 pathway. J. Bone Miner. Res. 23: 750-758.   DOI   ScienceOn
8 Suzuki M, Kumagai K, Osaki M, Murata M, Tomita M, Miyata N, et al. 2008. Osteonecrosis of femoral head in the stroke-prone spontaneously hypertensive rats, especially old rats. Clin. Exp. Hypertens. 30: 689-697.   DOI   ScienceOn
9 Tateda K, Matsumoto T, Miyazaki S, Yamaguchi K. 1996. Lipopolysaccharide-induced lethality and cytokine production in aged mice. Infect. Immun. 64: 769-774.
10 Triantafilou M, Triantafilou K. 2005. The dynamics of LPS recognition: complex orchestration of multiple receptors. J. Endotoxin Res. 11: 5-11.
11 Kim HK, S tephenson N, G arces A , Aya- ay J, Bian H . 2009. Effects of disruption of epiphyseal vasculature on the proximal femoral growth plate. J. Bone Joint Surg. Am. 91: 1149-1158.   DOI   ScienceOn
12 Kogianni G, Mann V, Ebetino F, Nuttall M, Nijweide P, Simpson H, Noble B. 2004. Fas/CD95 is associated with glucocorticoid-induced osteocyte apoptosis. Life Sci. 75: 2879-2895.   DOI   ScienceOn
13 Laroche M. 2002. Intraosseous circulation from physiology to disease. Joint Bone Spine 69: 262-269.   DOI   ScienceOn
14 Manolagas SC. 2000. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr. Rev. 21: 115-137.
15 Lu YC, Yeh WC, Ohashi PS. 2008. LPS/TLR4 signal transduction pathway. Cytokine 42: 145-151.   DOI   ScienceOn
16 Kerachian MA, Seguin C, Harvey EJ. 2009. Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action. J. Steroid Biochem. Mol. Biol. 114: 121-128.   DOI   ScienceOn
17 Macias MP, Fitzpatrick LA, Brenneise I, McGarry MP, Lee JJ, Lee NA. 2001. Expression of IL-5 alters bone metabolism and induces ossification of the spleen in transgenic mice. J. Clin. Invest. 107: 949-959.   DOI   ScienceOn
18 Kim HK, B ian H, A ya- ay J , Garces A , Morgan E F, Gilbert SR. 2009. Hypoxia and HIF-1alpha expression in the epiphyseal cartilage following ischemic injury to the immature femoral head. Bone 45: 280-288.   DOI   ScienceOn
19 Miossec P, Briolay J, Dechanet J, Wijdenes J, Martinez- Valdez H, Banchereau J. 1992. Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis. Arthritis Rheum. 35: 874-883.   DOI   ScienceOn
20 Moraes LA, Paul-Clark MJ, Rickman A, Flower RJ, Goulding NJ, Perretti M. 2005. Ligand-specific glucocorticoid receptor activation in human platelets. Blood 106: 4167-4175.   DOI   ScienceOn
21 Gridley DS, Miller GM, Pecaut MJ. 2007. Radiation and primary response to lipopolysaccharide: bone marrow-derived cells and susceptible organs. In Vivo 21: 453-461.
22 Horber FF, Scheidegger JR, Grunig BE, Frey FJ. 1985. Thigh muscle mass and function in patients treated with glucocorticoids. Eur. J. Clin. Invest. 15: 302-307.   DOI
23 Ishimi Y, Miyaura C, Jin CH, Akatsu T, Abe E, Nakamura Y, et al. 1990. IL-6 is produced by osteoblasts and induces bone resorption. J. Immunol. 145: 3297-3303.
24 Aderem A, Ulevitch RJ. 2000. Toll-like receptors in the induction of the innate immune response. Nature 406: 782-787.   DOI   ScienceOn
25 Iuchi T, Akaike M, Mitsui T, Ohshima Y, Shintani Y, Azuma H, Matsumoto T. 2003. Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ. Res. 92: 81-87.   DOI   ScienceOn
26 Jones JP. 2000. [Epidemiological risk factors for non-traumatic osteonecrosis]. Orthopade 29: 370-379.
27 Kadono H, Kido J, Kataoka M, Yamauchi N, Nagata T. 1999. Inhibition of osteoblastic cell differentiation by lipopolysaccharide extract from Porphyromonas gingivalis. Infect. Immun. 67: 2841-2846.
28 Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME. 2002. Pathogenesis and natural history of osteonecrosis. Semin. Arthritis Rheum. 32: 94-124.   DOI
29 Kerachian MA, Cournoyer D, Harvey EJ, Chow TY, Begin LR, Nahal A, Seguin C. 2010. New insights into the pathogenesis of glucocorticoid-induced avascular necrosis: microarray analysis of gene expression in a rat model. Arthritis Res. Ther. 12: R124.   DOI
30 Kerachian MA, Harvey EJ, Cournoyer D, Chow TY, Seguin C. 2006. Avascular necrosis of the femoral head: vascular hypotheses. Endothelium 13: 237-244.   DOI   ScienceOn
31 Bejar J, Peled E, Boss JH. 2005. Vasculature deprivation - induced osteonecrosis of the rat femoral head as a model for therapeutic trials. Theor. Biol. Med. Model. 2: 24.   DOI
32 Bendixen AC, Shevde NK, Dienger KM, Willson TM, Funk CD, Pike JW. 2001. IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1. Proc. Natl. Acad. Sci. USA 98: 2443-2448.   DOI
33 Berger FM. 1967. The effect of endotoxin on resistance to infection and disease. Adv. Pharmacol. 5: 19-46.   DOI
34 Blotta MH, DeKruyff RH, Umetsu DT. 1997. Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. J. Immunol. 158: 5589-5595.
35 Dobrovolskaia MA, Vogel SN. 2002. Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microb. Infect. 4: 903-914.   DOI   ScienceOn
36 Cavaillon JM, Adib-Conquy M. 2006. Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit. Care 10: 233.   DOI
37 Chao YC, Wang SJ, Chu HC, Chang WK, Hsieh TY. 2003. Investigation of alcohol metabolizing enzyme genes in Chinese alcoholics with avascular necrosis of hip joint, pancreatitis and cirrhosis of the liver. Alcohol Alcohol. 38: 431-436.   DOI
38 Conaway HH, Grigorie D, Lerner UH. 1997. Differential effects of glucocorticoids on bone resorption in neonatal mouse calvariae stimulated by peptide and steroid-like hormones. J. Endocrinol. 155: 513-521.   DOI
39 Elenkov IJ, Papanicolaou DA, Wilder RL, Chrousos GP. 1996. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc. Assoc. Am. Physicians 108: 374-381.
40 Franchimont D, Louis E, Dewe W, Martens H, Vrindts- Gevaert Y, De Groote D, et al. 1998. Effects of dexamethasone on the profile of cytokine secretion in human whole blood cell cultures. Regul. Pept. 73: 59-65.   DOI